Government shrugs off price disclosure report

The federal health department has shrugged off Monday’s Grattan Institute report which says price disclosure does not go far enough.

A department spokesperson says price disclosure has achieved significant reductions in medicine prices and is on track to save $20 billion by 2019-20.

“The Australian government is providing affordable access to more lifesaving drugs than ever before – in the past few years  $5 billion worth of drugs have been added to the PBS.”

The spokesperson highlighted problems with the report’s call for generic drug wholesale costs to be based on the cheapest international pricing

One concern was that the report, titled Cutting a better drug deal, considered only the impact of tighter measures on seven of the more than 800 PBS medicines.

Of these seven drugs, pricing levels were